APO Research
Talk to an analyst

APO RESEARCH · REPORT

Selective Immunosuppressants

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Selective Immunosuppressants Industry Growth and Trends Forecast to 2032

27 December 2025125 pages

Choose your research edition.

Industry ResearchSelective Immunosuppressants Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Selective Immunosuppressants Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Selective Immunosuppressants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Selective Immunosuppressants Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Selective Immunosuppressants Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Selective Immunosuppressants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Selective Immunosuppressants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Selective Immunosuppressants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Selective Immunosuppressants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Selective Immunosuppressants include Chongqing Laimi Pharmaceutical Co., Ltd., Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., Shijiazhuang Huaxin Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Merro Pharmaceutical Co., Ltd. and Jiangsu Yabang Epson Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Selective Immunosuppressants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Selective Immunosuppressants market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Selective Immunosuppressants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Selective Immunosuppressants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Selective Immunosuppressants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Selective Immunosuppressants Market by Company

Chongqing Laimi Pharmaceutical Co., Ltd.

Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.

Shijiazhuang Huaxin Pharmaceutical Co., Ltd.

Xiamen Lizhuo Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Merro Pharmaceutical Co., Ltd.

Jiangsu Yabang Epson Pharmaceutical Co., Ltd.

Jichuang Pharmaceutical Group Co., Ltd.

North China Pharmaceutical Co., Ltd.

Hunan Warner Pharmaceutical Co., Ltd.

Hubei Tianyi Pharmaceutical Co., Ltd.

Fujian Huitian Biopharmaceutical Co., Ltd.

Chenxin Pharmaceutical Co., Ltd.

Changzhou Watson Pharmaceutical Co., Ltd.

Beijing Shuanglu Pharmaceutical Co., Ltd.

Teva

Sanofi

Pfizer

Manus Aktteva Biopharma LLP

Lupin Pharmaceuticals, Inc.

Glenmark Pharmaceuticals US

Alexion Pharmaceuticals, Inc

Selective Immunosuppressants Segment by Type

Leflunomide

Mycophenolate Mofetil

Mycophenolate Sodium

Teriflunomide Tablets

Tofacitinib

Sirolimus

Other

Selective Immunosuppressants Segment by Application

Hospital

Clinic

Other

Selective Immunosuppressants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Selective Immunosuppressants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Selective Immunosuppressants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Selective Immunosuppressants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Selective Immunosuppressants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Selective Immunosuppressants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Leflunomide Table 2. Major Company of Mycophenolate Mofetil Table 3. Major Company of Mycophenolate Sodium Table 4. Major Company of Teriflunomide Tablets Table 5. Major Company of Tofacitinib Table 6. Major Company of Sirolimus Table 7. Major Company of Other Table 8. Global Selective Immunosuppressants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Selective Immunosuppressants Sales by Type (2021-2026) & (K Units) Table 10. Global Selective Immunosuppressants Sales Market Share in Volume by Type (2021-2026) Table 11. Global Selective Immunosuppressants Sales by Type (2021-2026) & (US$ Million) Table 12. Global Selective Immunosuppressants Sales Market Share in Value by Type (2021-2026) Table 13. Global Selective Immunosuppressants Price by Type (2021-2026) & (US$/Unit) Table 14. Global Selective Immunosuppressants Sales by Type (2027-2032) & (K Units) Table 15. Global Selective Immunosuppressants Sales Market Share in Volume by Type (2027-2032) Table 16. Global Selective Immunosuppressants Sales by Type (2027-2032) & (US$ Million) Table 17. Global Selective Immunosuppressants Sales Market Share in Value by Type (2027-2032) Table 18. Global Selective Immunosuppressants Price by Type (2027-2032) & (US$/Unit) Table 19. North America Selective Immunosuppressants Sales by Type (2021-2026) & (K Units) Table 20. North America Selective Immunosuppressants Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Selective Immunosuppressants Sales by Type (2021-2026) & (K Units) Table 22. Europe Selective Immunosuppressants Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Selective Immunosuppressants Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Selective Immunosuppressants Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Selective Immunosuppressants Sales by Type (2021-2026) & (K Units) Table 26. Latin America Selective Immunosuppressants Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Selective Immunosuppressants Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Selective Immunosuppressants Sales by Type (2021-2026) & (US$ Million) Table 29. Selective Immunosuppressants Industry Trends Table 30. Selective Immunosuppressants Industry Drivers Table 31. Selective Immunosuppressants Industry Opportunities and Challenges Table 32. Selective Immunosuppressants Industry Restraints Table 33. Global Selective Immunosuppressants Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Selective Immunosuppressants Revenue Market Share by Company (2021-2026) Table 35. Global Selective Immunosuppressants Sales by Company (2021-2026) & (K Units) Table 36. Global Selective Immunosuppressants Sales Share by Company (2021-2026) Table 37. Global Selective Immunosuppressants Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Selective Immunosuppressants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Selective Immunosuppressants Major Company Production Sites and Headquarters Table 40. Global Selective Immunosuppressants Company, Product Type & Application Table 41. Global Selective Immunosuppressants Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Selective Immunosuppressants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Selective Immunosuppressants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Selective Immunosuppressants Sales by Region (2021-2026) & (K Units) Table 46. Global Selective Immunosuppressants Sales Market Share in Volume by Region (2021-2026) Table 47. Global Selective Immunosuppressants Sales by Region (2021-2026) & (US$ Million) Table 48. Global Selective Immunosuppressants Sales Market Share in Value by Region (2021-2026) Table 49. Global Selective Immunosuppressants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Selective Immunosuppressants Sales by Region (2027-2032) & (K Units) Table 51. Global Selective Immunosuppressants Sales Market Share in Volume by Region (2027-2032) Table 52. Global Selective Immunosuppressants Sales by Region (2027-2032) & (US$ Million) Table 53. Global Selective Immunosuppressants Sales Market Share in Value by Region (2027-2032) Table 54. Global Selective Immunosuppressants Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Selective Immunosuppressants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Selective Immunosuppressants Sales by Application (2021-2026) & (K Units) Table 57. Global Selective Immunosuppressants Sales Market Share in Volume by Application (2021-2026) Table 58. Global Selective Immunosuppressants Sales by Application (2021-2026) & (US$ Million) Table 59. Global Selective Immunosuppressants Sales Market Share in Value by Application (2021-2026) Table 60. Global Selective Immunosuppressants Price by Application (2021-2026) & (US$/Unit) Table 61. Global Selective Immunosuppressants Sales by Application (2027-2032) & (K Units) Table 62. Global Selective Immunosuppressants Sales Market Share in Volume by Application (2027-2032) Table 63. Global Selective Immunosuppressants Sales by Application (2027-2032) & (US$ Million) Table 64. Global Selective Immunosuppressants Sales Market Share in Value by Application (2027-2032) Table 65. Global Selective Immunosuppressants Price by Application (2027-2032) & (US$/Unit) Table 66. North America Selective Immunosuppressants Sales by Application (2021-2026) & (K Units) Table 67. North America Selective Immunosuppressants Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Selective Immunosuppressants Sales by Application (2021-2026) & (K Units) Table 69. Europe Selective Immunosuppressants Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Selective Immunosuppressants Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Selective Immunosuppressants Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Selective Immunosuppressants Sales by Application (2021-2026) & (K Units) Table 73. Latin America Selective Immunosuppressants Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Selective Immunosuppressants Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Selective Immunosuppressants Sales by Application (2021-2026) & (US$ Million) Table 76. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information Table 77. Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview Table 78. Chongqing Laimi Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Chongqing Laimi Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 80. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Development Table 81. Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Company Information Table 82. Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Business Overview Table 83. Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 85. Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Recent Development Table 86. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 87. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 88. Zhejiang Hisun Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Zhejiang Hisun Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 90. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 91. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information Table 92. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview Table 93. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 95. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Development Table 96. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Company Information Table 97. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Business Overview Table 98. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 100. Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Recent Development Table 101. Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information Table 102. Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview Table 103. Xiamen Lizhuo Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Xiamen Lizhuo Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 105. Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Development Table 106. Qilu Pharmaceutical Co., Ltd. Company Information Table 107. Qilu Pharmaceutical Co., Ltd. Business Overview Table 108. Qilu Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Qilu Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 110. Qilu Pharmaceutical Co., Ltd. Recent Development Table 111. Merro Pharmaceutical Co., Ltd. Company Information Table 112. Merro Pharmaceutical Co., Ltd. Business Overview Table 113. Merro Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Merro Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 115. Merro Pharmaceutical Co., Ltd. Recent Development Table 116. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information Table 117. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview Table 118. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 120. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Development Table 121. Jichuang Pharmaceutical Group Co., Ltd. Company Information Table 122. Jichuang Pharmaceutical Group Co., Ltd. Business Overview Table 123. Jichuang Pharmaceutical Group Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Jichuang Pharmaceutical Group Co., Ltd. Selective Immunosuppressants Product Portfolio Table 125. Jichuang Pharmaceutical Group Co., Ltd. Recent Development Table 126. North China Pharmaceutical Co., Ltd. Company Information Table 127. North China Pharmaceutical Co., Ltd. Business Overview Table 128. North China Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. North China Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 130. North China Pharmaceutical Co., Ltd. Recent Development Table 131. Hunan Warner Pharmaceutical Co., Ltd. Company Information Table 132. Hunan Warner Pharmaceutical Co., Ltd. Business Overview Table 133. Hunan Warner Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Hunan Warner Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 135. Hunan Warner Pharmaceutical Co., Ltd. Recent Development Table 136. Hubei Tianyi Pharmaceutical Co., Ltd. Company Information Table 137. Hubei Tianyi Pharmaceutical Co., Ltd. Business Overview Table 138. Hubei Tianyi Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Hubei Tianyi Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 140. Hubei Tianyi Pharmaceutical Co., Ltd. Recent Development Table 141. Fujian Huitian Biopharmaceutical Co., Ltd. Company Information Table 142. Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview Table 143. Fujian Huitian Biopharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Fujian Huitian Biopharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 145. Fujian Huitian Biopharmaceutical Co., Ltd. Recent Development Table 146. Chenxin Pharmaceutical Co., Ltd. Company Information Table 147. Chenxin Pharmaceutical Co., Ltd. Business Overview Table 148. Chenxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Chenxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 150. Chenxin Pharmaceutical Co., Ltd. Recent Development Table 151. Changzhou Watson Pharmaceutical Co., Ltd. Company Information Table 152. Changzhou Watson Pharmaceutical Co., Ltd. Business Overview Table 153. Changzhou Watson Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Changzhou Watson Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 155. Changzhou Watson Pharmaceutical Co., Ltd. Recent Development Table 156. Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information Table 157. Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview Table 158. Beijing Shuanglu Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Beijing Shuanglu Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio Table 160. Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Development Table 161. Teva Company Information Table 162. Teva Business Overview Table 163. Teva Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Teva Selective Immunosuppressants Product Portfolio Table 165. Teva Recent Development Table 166. Sanofi Company Information Table 167. Sanofi Business Overview Table 168. Sanofi Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Sanofi Selective Immunosuppressants Product Portfolio Table 170. Sanofi Recent Development Table 171. Pfizer Company Information Table 172. Pfizer Business Overview Table 173. Pfizer Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Pfizer Selective Immunosuppressants Product Portfolio Table 175. Pfizer Recent Development Table 176. Manus Aktteva Biopharma LLP Company Information Table 177. Manus Aktteva Biopharma LLP Business Overview Table 178. Manus Aktteva Biopharma LLP Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Manus Aktteva Biopharma LLP Selective Immunosuppressants Product Portfolio Table 180. Manus Aktteva Biopharma LLP Recent Development Table 181. Lupin Pharmaceuticals, Inc. Company Information Table 182. Lupin Pharmaceuticals, Inc. Business Overview Table 183. Lupin Pharmaceuticals, Inc. Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 184. Lupin Pharmaceuticals, Inc. Selective Immunosuppressants Product Portfolio Table 185. Lupin Pharmaceuticals, Inc. Recent Development Table 186. Glenmark Pharmaceuticals US Company Information Table 187. Glenmark Pharmaceuticals US Business Overview Table 188. Glenmark Pharmaceuticals US Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 189. Glenmark Pharmaceuticals US Selective Immunosuppressants Product Portfolio Table 190. Glenmark Pharmaceuticals US Recent Development Table 191. Alexion Pharmaceuticals, Inc Company Information Table 192. Alexion Pharmaceuticals, Inc Business Overview Table 193. Alexion Pharmaceuticals, Inc Selective Immunosuppressants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 194. Alexion Pharmaceuticals, Inc Selective Immunosuppressants Product Portfolio Table 195. Alexion Pharmaceuticals, Inc Recent Development Table 196. North America Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. North America Selective Immunosuppressants Sales by Country (2021-2026) & (K Units) Table 198. North America Selective Immunosuppressants Sales Market Share by Country (2021-2026) Table 199. North America Selective Immunosuppressants Sales Forecast by Country (2027-2032) & (K Units) Table 200. North America Selective Immunosuppressants Sales Market Share Forecast by Country (2027-2032) Table 201. North America Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. North America Selective Immunosuppressants Market Size by Country (2021-2026) & (US$ Million) Table 203. North America Selective Immunosuppressants Market Share by Country (2021-2026) Table 204. North America Selective Immunosuppressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. North America Selective Immunosuppressants Market Share Forecast by Country (2027-2032) Table 206. Europe Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Europe Selective Immunosuppressants Sales by Country (2021-2026) & (K Units) Table 208. Europe Selective Immunosuppressants Sales Market Share by Country (2021-2026) Table 209. Europe Selective Immunosuppressants Sales Forecast by Country (2027-2032) & (K Units) Table 210. Europe Selective Immunosuppressants Sales Market Share Forecast by Country (2027-2032) Table 211. Europe Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Europe Selective Immunosuppressants Market Size by Country (2021-2026) & (US$ Million) Table 213. Europe Selective Immunosuppressants Market Share by Country (2021-2026) Table 214. Europe Selective Immunosuppressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Europe Selective Immunosuppressants Market Share Forecast by Country (2027-2032) Table 216. Asia-Pacific Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 217. Asia-Pacific Selective Immunosuppressants Sales by Country (2021-2026) & (K Units) Table 218. Asia-Pacific Selective Immunosuppressants Sales Market Share by Country (2021-2026) Table 219. Asia-Pacific Selective Immunosuppressants Sales Forecast by Country (2027-2032) & (K Units) Table 220. Asia-Pacific Selective Immunosuppressants Sales Market Share Forecast by Country (2027-2032) Table 221. Asia-Pacific Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Asia-Pacific Selective Immunosuppressants Market Size by Country (2021-2026) & (US$ Million) Table 223. Asia-Pacific Selective Immunosuppressants Market Share by Country (2021-2026) Table 224. Asia-Pacific Selective Immunosuppressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Asia-Pacific Selective Immunosuppressants Market Share Forecast by Country (2027-2032) Table 226. Latin America Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 227. Latin America Selective Immunosuppressants Sales by Country (2021-2026) & (K Units) Table 228. Latin America Selective Immunosuppressants Sales Market Share by Country (2021-2026) Table 229. Latin America Selective Immunosuppressants Sales Forecast by Country (2027-2032) & (K Units) Table 230. Latin America Selective Immunosuppressants Sales Market Share Forecast by Country (2027-2032) Table 231. Latin America Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 232. Latin America Selective Immunosuppressants Market Size by Country (2021-2026) & (US$ Million) Table 233. Latin America Selective Immunosuppressants Market Share by Country (2021-2026) Table 234. Latin America Selective Immunosuppressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 235. Latin America Selective Immunosuppressants Market Share Forecast by Country (2027-2032) Table 236. Middle East and Africa Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 237. Middle East and Africa Selective Immunosuppressants Sales by Country (2021-2026) & (K Units) Table 238. Middle East and Africa Selective Immunosuppressants Sales Market Share by Country (2021-2026) Table 239. Middle East and Africa Selective Immunosuppressants Sales Forecast by Country (2027-2032) & (K Units) Table 240. Middle East and Africa Selective Immunosuppressants Sales Market Share Forecast by Country (2027-2032) Table 241. Middle East and Africa Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 242. Middle East and Africa Selective Immunosuppressants Market Size by Country (2021-2026) & (US$ Million) Table 243. Middle East and Africa Selective Immunosuppressants Market Share by Country (2021-2026) Table 244. Middle East and Africa Selective Immunosuppressants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 245. Middle East and Africa Selective Immunosuppressants Market Share Forecast by Country (2027-2032) Table 246. Key Raw Materials Table 247. Raw Materials Key Suppliers Table 248. Selective Immunosuppressants Distributors List Table 249. Selective Immunosuppressants Customers List Table 250. Research Programs/Design for This Report Table 251. Authors List of This Report Table 252. Secondary Sources Table 253. Primary Sources List of Figures Figure 1. Selective Immunosuppressants Image Figure 2. Global Selective Immunosuppressants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Selective Immunosuppressants Market Size (2021-2032) & (US$ Million) Figure 4. Global Selective Immunosuppressants Sales (2021-2032) & (K Units) Figure 5. Leflunomide Image Figure 6. Global Leflunomide Sales YoY Growth (2021-2032) & (K Units) Figure 7. Mycophenolate Mofetil Image Figure 8. Global Mycophenolate Mofetil Sales YoY Growth (2021-2032) & (K Units) Figure 9. Mycophenolate Sodium Image Figure 10. Global Mycophenolate Sodium Sales YoY Growth (2021-2032) & (K Units) Figure 11. Teriflunomide Tablets Image Figure 12. Global Teriflunomide Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 13. Tofacitinib Image Figure 14. Global Tofacitinib Sales YoY Growth (2021-2032) & (K Units) Figure 15. Sirolimus Image Figure 16. Global Sirolimus Sales YoY Growth (2021-2032) & (K Units) Figure 17. Other Image Figure 18. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Selective Immunosuppressants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Selective Immunosuppressants Market Share by Type 2025 VS 2032 Figure 21. North America Selective Immunosuppressants Sales Market Share in Volume by Type in 2025 Figure 22. North America Selective Immunosuppressants Sales Market Share in Value by Type in 2025 Figure 23. Europe Selective Immunosuppressants Sales Market Share in Volume by Type in 2025 Figure 24. Europe Selective Immunosuppressants Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Selective Immunosuppressants Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Selective Immunosuppressants Sales Market Share in Value by Type in 2025 Figure 27. Latin America Selective Immunosuppressants Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Selective Immunosuppressants Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Selective Immunosuppressants Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Selective Immunosuppressants Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Selective Immunosuppressants Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Selective Immunosuppressants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Selective Immunosuppressants Market Share by Application 2025 VS 2032 Figure 41. North America Selective Immunosuppressants Sales Market Share in Volume by Application in 2025 Figure 42. North America Selective Immunosuppressants Sales Market Share in Value by Application in 2025 Figure 43. Europe Selective Immunosuppressants Sales Market Share in Volume by Application in 2025 Figure 44. Europe Selective Immunosuppressants Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Selective Immunosuppressants Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Selective Immunosuppressants Sales Market Share in Value by Application in 2025 Figure 47. Latin America Selective Immunosuppressants Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Selective Immunosuppressants Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Selective Immunosuppressants Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Selective Immunosuppressants Sales Market Share in Value by Application in 2025 Figure 51. North America Selective Immunosuppressants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Selective Immunosuppressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Selective Immunosuppressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Selective Immunosuppressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Selective Immunosuppressants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Selective Immunosuppressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Selective Immunosuppressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Selective Immunosuppressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Selective Immunosuppressants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Selective Immunosuppressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Selective Immunosuppressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Selective Immunosuppressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Selective Immunosuppressants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Selective Immunosuppressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Selective Immunosuppressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Selective Immunosuppressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Selective Immunosuppressants Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Selective Immunosuppressants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Selective Immunosuppressants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Selective Immunosuppressants Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Selective Immunosuppressants Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Selective Immunosuppressants Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Leflunomide
  • Mycophenolate Mofetil
  • Mycophenolate Sodium
  • Teriflunomide Tablets
  • Tofacitinib
  • Sirolimus
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Laimi Pharmaceutical Co., Ltd.
  • Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  • Shijiazhuang Huaxin Pharmaceutical Co., Ltd.
  • Xiamen Lizhuo Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Merro Pharmaceutical Co., Ltd.
  • Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  • Jichuang Pharmaceutical Group Co., Ltd.
  • North China Pharmaceutical Co., Ltd.
  • Hunan Warner Pharmaceutical Co., Ltd.
  • Hubei Tianyi Pharmaceutical Co., Ltd.
  • Fujian Huitian Biopharmaceutical Co., Ltd.
  • Chenxin Pharmaceutical Co., Ltd.
  • Changzhou Watson Pharmaceutical Co., Ltd.
  • Beijing Shuanglu Pharmaceutical Co., Ltd.
  • Teva
  • Sanofi
  • Pfizer
  • Manus Aktteva Biopharma LLP
  • Lupin Pharmaceuticals, Inc.
  • Glenmark Pharmaceuticals US
  • Alexion Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Selective Immunosuppressants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Selective Immunosuppressants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Selective Immunosuppressants Market by Type
  6. 1.3.1 Leflunomide
  7. 1.3.2 Mycophenolate Mofetil
  8. 1.3.3 Mycophenolate Sodium
  9. 1.3.4 Teriflunomide Tablets
  10. 1.3.5 Tofacitinib
  11. 1.3.6 Sirolimus
  12. 1.3.7 Other
  13. 1.4 Global Selective Immunosuppressants Market Size by Type
  14. 1.4.1 Global Selective Immunosuppressants Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Selective Immunosuppressants Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Selective Immunosuppressants Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Selective Immunosuppressants Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Selective Immunosuppressants Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Selective Immunosuppressants Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Selective Immunosuppressants Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Selective Immunosuppressants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Selective Immunosuppressants Industry Trends
  2. 2.2 Selective Immunosuppressants Industry Drivers
  3. 2.3 Selective Immunosuppressants Industry Opportunities and Challenges
  4. 2.4 Selective Immunosuppressants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Selective Immunosuppressants Revenue (2021-2026)
  2. 3.2 Global Top Players by Selective Immunosuppressants Sales (2021-2026)
  3. 3.3 Global Top Players by Selective Immunosuppressants Price (2021-2026)
  4. 3.4 Global Selective Immunosuppressants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Selective Immunosuppressants Major Company Production Sites & Headquarters
  6. 3.6 Global Selective Immunosuppressants Company, Product Type & Application
  7. 3.7 Global Selective Immunosuppressants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Selective Immunosuppressants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Selective Immunosuppressants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Selective Immunosuppressants Tier 1, Tier 2, and Tier 3
4 Selective Immunosuppressants Regional Status and Outlook
  1. 4.1 Global Selective Immunosuppressants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Selective Immunosuppressants Historic Market Size by Region
  3. 4.2.1 Global Selective Immunosuppressants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Selective Immunosuppressants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Selective Immunosuppressants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Selective Immunosuppressants Forecasted Market Size by Region
  7. 4.3.1 Global Selective Immunosuppressants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Selective Immunosuppressants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Selective Immunosuppressants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Selective Immunosuppressants by Application
  1. 5.1 Selective Immunosuppressants Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Selective Immunosuppressants Market Size by Application
  6. 5.2.1 Global Selective Immunosuppressants Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Selective Immunosuppressants Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Selective Immunosuppressants Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Selective Immunosuppressants Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Selective Immunosuppressants Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Selective Immunosuppressants Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Selective Immunosuppressants Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Selective Immunosuppressants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Laimi Pharmaceutical Co., Ltd.
  2. 6.1.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Chongqing Laimi Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Chongqing Laimi Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Laimi Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  6. 6.1.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd.
  8. 6.2.1 Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  12. 6.2.5 Zhejiang Sansheng Mandi Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Zhejiang Hisun Pharmaceutical Co., Ltd.
  14. 6.3.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  18. 6.3.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
  20. 6.4.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  24. 6.4.5 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Shijiazhuang Huaxin Pharmaceutical Co., Ltd.
  26. 6.5.1 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  30. 6.5.5 Shijiazhuang Huaxin Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Xiamen Lizhuo Pharmaceutical Co., Ltd.
  32. 6.6.1 Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Xiamen Lizhuo Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Xiamen Lizhuo Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Xiamen Lizhuo Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  36. 6.6.5 Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Qilu Pharmaceutical Co., Ltd.
  38. 6.7.1 Qilu Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Qilu Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Qilu Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  42. 6.7.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Merro Pharmaceutical Co., Ltd.
  44. 6.8.1 Merro Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Merro Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Merro Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merro Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  48. 6.8.5 Merro Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
  50. 6.9.1 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  54. 6.9.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Jichuang Pharmaceutical Group Co., Ltd.
  56. 6.10.1 Jichuang Pharmaceutical Group Co., Ltd. Company Information
  57. 6.10.2 Jichuang Pharmaceutical Group Co., Ltd. Business Overview
  58. 6.10.3 Jichuang Pharmaceutical Group Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jichuang Pharmaceutical Group Co., Ltd. Selective Immunosuppressants Product Portfolio
  60. 6.10.5 Jichuang Pharmaceutical Group Co., Ltd. Recent Developments
  61. 6.11 North China Pharmaceutical Co., Ltd.
  62. 6.11.1 North China Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 North China Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 North China Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 North China Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  66. 6.11.5 North China Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Hunan Warner Pharmaceutical Co., Ltd.
  68. 6.12.1 Hunan Warner Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Hunan Warner Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Hunan Warner Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hunan Warner Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  72. 6.12.5 Hunan Warner Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Hubei Tianyi Pharmaceutical Co., Ltd.
  74. 6.13.1 Hubei Tianyi Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Hubei Tianyi Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Hubei Tianyi Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hubei Tianyi Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  78. 6.13.5 Hubei Tianyi Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Fujian Huitian Biopharmaceutical Co., Ltd.
  80. 6.14.1 Fujian Huitian Biopharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Fujian Huitian Biopharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Fujian Huitian Biopharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Fujian Huitian Biopharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  84. 6.14.5 Fujian Huitian Biopharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Chenxin Pharmaceutical Co., Ltd.
  86. 6.15.1 Chenxin Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Chenxin Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Chenxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Chenxin Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  90. 6.15.5 Chenxin Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Changzhou Watson Pharmaceutical Co., Ltd.
  92. 6.16.1 Changzhou Watson Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Changzhou Watson Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Changzhou Watson Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Changzhou Watson Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  96. 6.16.5 Changzhou Watson Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Beijing Shuanglu Pharmaceutical Co., Ltd.
  98. 6.17.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Selective Immunosuppressants Product Portfolio
  102. 6.17.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Teva
  104. 6.18.1 Teva Company Information
  105. 6.18.2 Teva Business Overview
  106. 6.18.3 Teva Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Teva Selective Immunosuppressants Product Portfolio
  108. 6.18.5 Teva Recent Developments
  109. 6.19 Sanofi
  110. 6.19.1 Sanofi Company Information
  111. 6.19.2 Sanofi Business Overview
  112. 6.19.3 Sanofi Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Sanofi Selective Immunosuppressants Product Portfolio
  114. 6.19.5 Sanofi Recent Developments
  115. 6.20 Pfizer
  116. 6.20.1 Pfizer Company Information
  117. 6.20.2 Pfizer Business Overview
  118. 6.20.3 Pfizer Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Pfizer Selective Immunosuppressants Product Portfolio
  120. 6.20.5 Pfizer Recent Developments
  121. 6.21 Manus Aktteva Biopharma LLP
  122. 6.21.1 Manus Aktteva Biopharma LLP Company Information
  123. 6.21.2 Manus Aktteva Biopharma LLP Business Overview
  124. 6.21.3 Manus Aktteva Biopharma LLP Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Manus Aktteva Biopharma LLP Selective Immunosuppressants Product Portfolio
  126. 6.21.5 Manus Aktteva Biopharma LLP Recent Developments
  127. 6.22 Lupin Pharmaceuticals, Inc.
  128. 6.22.1 Lupin Pharmaceuticals, Inc. Company Information
  129. 6.22.2 Lupin Pharmaceuticals, Inc. Business Overview
  130. 6.22.3 Lupin Pharmaceuticals, Inc. Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Lupin Pharmaceuticals, Inc. Selective Immunosuppressants Product Portfolio
  132. 6.22.5 Lupin Pharmaceuticals, Inc. Recent Developments
  133. 6.23 Glenmark Pharmaceuticals US
  134. 6.23.1 Glenmark Pharmaceuticals US Company Information
  135. 6.23.2 Glenmark Pharmaceuticals US Business Overview
  136. 6.23.3 Glenmark Pharmaceuticals US Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Glenmark Pharmaceuticals US Selective Immunosuppressants Product Portfolio
  138. 6.23.5 Glenmark Pharmaceuticals US Recent Developments
  139. 6.24 Alexion Pharmaceuticals, Inc
  140. 6.24.1 Alexion Pharmaceuticals, Inc Company Information
  141. 6.24.2 Alexion Pharmaceuticals, Inc Business Overview
  142. 6.24.3 Alexion Pharmaceuticals, Inc Selective Immunosuppressants Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Alexion Pharmaceuticals, Inc Selective Immunosuppressants Product Portfolio
  144. 6.24.5 Alexion Pharmaceuticals, Inc Recent Developments
7 North America by Country
  1. 7.1 North America Selective Immunosuppressants Sales by Country
  2. 7.1.1 North America Selective Immunosuppressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Selective Immunosuppressants Sales by Country (2021-2026)
  4. 7.1.3 North America Selective Immunosuppressants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Selective Immunosuppressants Market Size by Country
  6. 7.2.1 North America Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Selective Immunosuppressants Market Size by Country (2021-2026)
  8. 7.2.3 North America Selective Immunosuppressants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Selective Immunosuppressants Sales by Country
  2. 8.1.1 Europe Selective Immunosuppressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Selective Immunosuppressants Sales by Country (2021-2026)
  4. 8.1.3 Europe Selective Immunosuppressants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Selective Immunosuppressants Market Size by Country
  6. 8.2.1 Europe Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Selective Immunosuppressants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Selective Immunosuppressants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Selective Immunosuppressants Sales by Country
  2. 9.1.1 Asia-Pacific Selective Immunosuppressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Selective Immunosuppressants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Selective Immunosuppressants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Selective Immunosuppressants Market Size by Country
  6. 9.2.1 Asia-Pacific Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Selective Immunosuppressants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Selective Immunosuppressants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Selective Immunosuppressants Sales by Country
  2. 10.1.1 South America Selective Immunosuppressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Selective Immunosuppressants Sales by Country (2021-2026)
  4. 10.1.3 South America Selective Immunosuppressants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Selective Immunosuppressants Market Size by Country
  6. 10.2.1 South America Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Selective Immunosuppressants Market Size by Country (2021-2026)
  8. 10.2.3 South America Selective Immunosuppressants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Selective Immunosuppressants Sales by Country
  2. 11.1.1 Middle East and Africa Selective Immunosuppressants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Selective Immunosuppressants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Selective Immunosuppressants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Selective Immunosuppressants Market Size by Country
  6. 11.2.1 Middle East and Africa Selective Immunosuppressants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Selective Immunosuppressants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Selective Immunosuppressants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Selective Immunosuppressants Value Chain Analysis
  2. 12.1.1 Selective Immunosuppressants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Selective Immunosuppressants Production Mode & Process
  7. 12.2 Selective Immunosuppressants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Selective Immunosuppressants Distributors
  10. 12.2.3 Selective Immunosuppressants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst